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Background: China has made large efforts to reduce stroke prevalence. We aimed to systematically 
examine the prevalence of stroke in China over the past two decades. 
Methods: Databases, including China National Knowledge Infrastructure, Wanfang, VIP, and PubMed, 
were systematically searched for studies published in English or Chinese that reported stroke prevalence in 
China during 2000–2017. Meta-analysis was conducted to estimate the pooled stroke prevalence and the 
variations in stroke prevalence subgroups stratified by age, gender, time period, and region. 
Results: In total, 96 papers met the inclusion criteria. Meta-analysis showed that the overall estimated 
national prevalence was 5.1% (5.0–5.3%) with large variations across regions: 3.1% (2.5–3.6%) in south 
China, 3.4% (3.0–3.8%) in southwest China, 3.6% (3.3–3.8%) in east China, 5.0% (4.7–5.4%) in central 
China, 5.8% (4.6–7.1%) in northwest China, 6.0% (5.0–7.0%) in northeast China, and 8.0% (7.4–8.5%) 
in north China. Men had a higher prevalence than women [7.3% (6.9–7.7%) vs. 5.6% (5.2–6.0%)]. Stroke 
prevalence increased with age, was 1.2% (1.0–1.3%), 2.9% (2.6–3.2%), 5.9% (5.2–6.5%), and 8.7% (8.0–
9.5%) in the 40–49, 50–59, 60–69, and ≥70 years old groups, respectively. 
Conclusions: Men, people being older, or living in northern China had higher stroke prevalence. More 
vigorous efforts are needed in China to prevent stroke. 
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Introduction
Stroke is the second leading cause of death worldwide and 
in China, where a fifth of the world’s population resides. 
With over 2 million new cases annually, stroke is associated 
with the highest disability-adjusted life-years lost among all 
chronic diseases in China (1-3). The burden of stroke has 
increased worldwide because of shifts in people’s lifestyles 
and population aging, especially in low- and middle-income 
countries (4). Stroke also creates tremendous economic 
pressure on health care systems (5,6). The annual incidence 
of stroke is expected to increase to over 23 million and 
annual deaths to 7.8 million by 2030 in the absence of 
effective global public health responses (7,8).
In China, about 2.4 million people have a new onset 
of stroke each year. About 75% of individuals living with 
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stroke will develop neurological sequela that leads to various 
degrees of disability (9,10). Stroke also brings a heavy 
financial burden to the affected families and society. Over 
the past decade, China has implemented several national 
and regional programs for stroke prevention and control. 
These included the well-known Healthy China 2020 and 
Healthy China 2030 programs that were launched in 2012 
and 2016, respectively. Regional reports show the beneficial 
effects of these programs, with a risk of stroke in high-risk 
individuals and the general population possibly benefitting 
more than others from such programs (11). A systematic 
examination of the trends of stroke prevalence in China will 
enable us to gain important insights into the effectiveness of 
these intervention programs.
This study aimed to systematically examine the temporal 
changes in the prevalence of stroke and also differences in 
the prevalence stratified by age, gender, and region over 
the past two decades in China. This information will aid 
intervention efforts in future. We present the following 
article in accordance with the PRISMA reporting checklist 
(available at http://dx.doi.org/10.21037/atm-19-4342) (12). 
Methods 
Literature search
We searched the following databases: (I) the China National 
Knowledge Infrastructure (CNKI) (http://www.cnki.net/); (II) 
Wanfang Database (http://www.wanfangdata.com.cn/index.
html); (III) China Science and Technology Journal Database 
(VIP) Database (http://www.cqvip.com/); and (IV) PubMed 
(https://www.ncbi.nlm.nih.gov/pmc/). We searched for 
studies published between January 1, 2000, and December 
31, 2017, using the search terms “stroke” OR “transient 
ischemic attack” OR “intracerebral hemorrhage” OR “isch(a)
emic stroke” OR” intraparenchymal” OR “subarachnoid” 
OR “h(a)emorrhage” AND “Chinese” OR “China” AND 
“prevalence” OR “epidemic.” We also reviewed the reference 
lists of the retrieved publications to identify any additional 
relevant studies. Our meta-analysis was conducted according 
to the preferred reporting items of the Meta-Analysis of 
Observational Studies in Epidemiology (MOOSE) statement 
for meta-analyses of observational studies (13).
Study selection
Studies were included if they met the following criteria: (I) 
the study population was Chinese; (II) the study population 
was aged 40 and over; (III) participants were selected from 
the general population or those who undertook routine 
physical examinations organized by employers; (IV) the 
main outcome was the prevalence of stroke; (V) a cross-
sectional study or large cohort study for monitoring 
purposes; (VI) sample size >1,000; and (VII) age-specific 
data were presented.
Studies were excluded when meeting the following 
criteria: (I) no age-specific data were provided and a single 
age group over 30 years; (II) the number of participants 
was not provided or the confidence interval could not be 
estimated; (III) the papers were published repeatedly; or 
(IV) participants were hospitalized patients or patients with 
certain diseases or other special groups (such as pregnant 
females, nursing mothers, smoking, drinking, military 
police, athletes, and those on weight loss or diet programs).
Our initial screening resulted in 3,016, 3,033, 2,272, 
and 1,577 articles from the CNKI, Wanfang, VIP, and 
PubMed databases, respectively. Ninety-six studies met 
the inclusion criteria (Figure 1). Two authors separately 
reviewed the studies. When there were differences between 
their assessments, a third author provided an additional 
assessment.
Data extraction
We extracted prevalence data of cross-sectional studies 
and cohort studies in the general population using a 
standardized data-collection form that included the 
following information: authors, publication year, study 
design, study aim/objective, study period, region, sample 
sizes, stroke prevalence (%) and 95% confidence interval 
(CI). Seven geographic regions in China were defined as 
north (Beijing, Tianjin, Hebei, Shanxi, and Inner Mongolia); 
northeast (Liaoning, Jilin, and Heilongjiang); northwest 
(Ningxia, Xinjiang, Qinghai, Shaanxi, and Gansu); central 
(Hubei, Hunan, and Henan); east (Shandong, Jiangsu, 
Anhui, Zhejiang, Fujian, Jiangxi, and Shanghai); southwest 
(Sichuan, Yunnan, Guizhou, Tibet, and Chongqing); south 
(Guangdong, Guangxi, and Hainan); special administrative 
region (Hong Kong and Macau); and Taiwan.
Quality of literature evaluation
For evaluation of the included studies, we used the 
literature quality assessment criteria proposed by Suriah 
AR, Chong TJ and Yeoh BY (Table S1) (14). Based on 
these quality assessment criteria, studies were scored 
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from 1 to 5 (highest to lowest quality score, respectively). 
A score of 1= nationally representative studies with 
large sample sizes and that employed random selection 
techniques; a score of 2= large, randomly selected 
samples from an entire state in the country; a score 
of 3= employed random selection techniques within a 
specified number of sampling units (e.g., two towns, three 
clinics); a score of 4= included large sample sizes (>1,000 
persons) even though the samples were not randomly 
selected; and a score of 5= small, non-randomly selected 
samples (14). The literature research yielded 96 eligible 
studies (Table S2). Of these, 29 studies reported gender-
Figure 1 Flowchart of systematic review procedure to select the 96 studies included.
Duplicates (N=1,206)
Full text articles to screen (N=466) 
Titles and abstracts for the primary screening 
(N=8,692)




Study of population under 18 years (n=783);
Clinical studies in hospital patients and special 
groups (n=2,982);
Sample size less than 1,000 (n=684)
Excluded =370: 
The single age grouping was over 30 years(N=21);
Survey time was not in 1998–2017 and published 
time was not in 2000 to 2017 (N=43);
Review article (N=42);
Literatures could not be standardized (N=264)
96 studies included 
Total articles identified (N=9,898) 
CNKI (N=3,016)              Wanfang (N=3,033) 
VIP (N=2,272)                  PubMed (N=1,577) 
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specific prevalence. Six were national surveys (Table S3). 
In general, the studies reviewed in this meta-analysis were 
of good quality: 36 studies scored 1, 48 studies scored 2, 
1 study scored 3, 11 studies scored 4. and 0 study scored 
5. We conducted a subgroup analysis of stroke prevalence 
among the five criteria used to evaluate the paper. The 
results showed no statistical significance (P=0.093).
Statistical analysis
The prevalence of stroke and its 95% CI were estimated 
using STATA/SE (Version 15.0; StataCorp LLC, College 
Station, TX, USA). The overall prevalence and age-, 
gender-, period-, and region-specific prevalence were 
estimated by meta-analysis, based on a random effects 
model. We estimated the pooled prevalence for each of the 
seven regions across China, and we divided the studies into 
the three periods of 2000–2005, 2006–2011, and 2012–2017 
based on the published dates. If the time or age spans 
covered different periods or age groups, we calculated the 
average value for the corresponding periods or age groups. 
We used the sixth Chinese census data in 2010 to calculate 
the age-standardized prevalence, and a linear regression 
model was conducted for trend tests for age and periods. 
Statistical significance was set at P<0.05.
Results
Overall stroke prevalence in China
We included a total of 96 studies that documented 169,958 
stroke cases in 3,332,502 participants. The overall estimate 
of the national prevalence of stroke was 5.1% (95% CI: 
5.0–5.3%). In particular, the pooled stroke prevalence rates 
were 5.2% (4.8–5.6%) in 2000–2005, 4.7% (4.5–4.9%) in 
2006–2011, and 5.4% (5.1–5.8%) in 2012–2017 (Table 1, 
Figure S1A).
Prevalence stratified by geographical regions
The prevalence varied across different regions, with 8.0% 
(7.4–8.5%) for north China, 6.0% (5.0–7.0%) for northeast 
China, 5.8% (4.6–7.1%) for northwest China, 5.0% (4.7–
5.4%) for central China, 3.6% (3.3–3.8%) for east China, 
3.4% (3.0–3.8%) for southwest China, 3.1% (2.5–3.6%) 
for south China, and 2.7% (2.3–3.0%) for Taiwan (Table 1). 
Stroke prevalence was the highest in the north and the 
lowest in the south of China (Figure 2).
At the provincial level, the prevalence ranged from the 
highest (8.9%) in Inner Mongolia to the lowest (0.6%) in 
Tibet. Within north China, the prevalence of stroke was 
high in Beijing (8.3%) and Inner Mongolia (8.9%), but low 
in Hebei (3.7%). The prevalence of stroke was below 5% 
in most of the provinces in south China, including 3.7% in 
Guangdong, 1.5% in Guangxi, and 2.7% in Taiwan.
Prevalence stratified by age group
The prevalence of stroke increased rapidly with age 
(Figure 3A), with prevalence rates of 1.2% (1.0–1.3%), 2.9% 
(2.6–3.2%), 5.9% (5.2–6.5%), and 8.7% (8.0–9.5%) in the 
40–49, 50–59, 60–69, and ≥70 age groups, respectively 
(Table 1). A significant increase in the prevalence of stroke 
was observed among those younger than 60. The prevalence 
of stroke among those aged 40–49 years doubled from 0.8% 
(0.5–1.0%) in 2000–2005 to 1.5% (1.2–1.8%) in 2012–2017. 
In comparison, the prevalence among those aged 50–59 had 
increased 1.7 times, from 2.0% (1.5–2.6%) in 2000–2005 to 
3.4% (2.8–4.0%) in 2012–2017 (Table 2). However, during 
the same period, the prevalence decreased slightly among 
those aged older than 60 (Table 2).
Prevalence stratified by gender
Based on 29 gender-specific studies, that included 465,276 
men (33,965 cases) and 335,708 women (18,800 cases), our 
analysis demonstrated that men [7.3% (6.9–7.7%)] had a 
higher prevalence of stroke than women [5.6% (5.2–6.0%)] 
(Figure 3B). When stratified by the time period, the pooled 
prevalence in men increased from 7.1% (6.0–8.3%) in 2000–
2005 to 7.3% (6.6–8.0%) in 2006–2011, then to 7.5% (6.7–
8.2%) in 2012–2017, whereas the corresponding prevalence 
in women were 5.4% (4.5–6.4%), 6.2% (5.5–6.8%), and 
5.2% (4.5–5.8%) (Table 1). When stratified by age groups, 
the prevalence rates in men were 1.2% (0.9–1.6%), 4.2% 
(3.3–5.1%), 7.8% (6.5–9.2%), and 12.0% (10.0–13.9%) in 
the age groups of 40–49, 50–59, 60–69, and ≥70, respectively. 
For women, the corresponding rates were 0.9% (0.6–1.1%), 
2.7% (2.1–3.3%), 5.9% (4.8–7.0%), and 9.4% (7.9–11.0%), 
respectively (Table 1). The overall prevalence of stroke in men 
was higher than that in women throughout all time periods 
(Figure S1B) in all different age groups (Figure 3C).
Discussion
We systematically examined the prevalence of stroke in 
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Chinese adults aged 40 and older based on studies published 
during 2000–2017. The overall prevalence of stroke was 
5.1% in China. Men had a higher rate of prevalence 
than women consistently, and the prevalence increased 
significantly in recent years for those aged 40–59, but it 
was relatively stable in those aged 60 and older. There were 
substantial regional differences in the rates of prevalence 
nationwide, with a high rate of prevalence in the north and 
a low one in the south.
The prevalence of stroke first decreased and then 
increased [5.2% (4.8–5.6%) in 2000–2005, 4.7% (4.5–4.9%) 
in 2006–2011, and 5.4% (5.1–5.8%) in 2012–2017] over 
the study period. However, the National Epidemiological 
Survey of Stroke in China highlighted a marked increase 
in stroke prevalence over the past decade (15). Due to data 
constraints, the temporal trend of stroke prevalence could 
not be analyzed annually. These may be subject to further 
investigation.
The stroke burden varied by regions. Consistent 
with previous findings (16), the prevalence of stroke in 
our study is higher in the north than in the south. Sun 
et al. showed that northeastern China had the highest 
incidence (441–486/100,000 person-years), whereas 
southern China had a significantly lower rate of incidence 
(81–136/100,000 person-years) (17). The difference 
is also in line with the difference of hypertension 
between north and south China. One study reported 
that the age-standardized prevalence of hypertension 
Table 1 Pooled stroke prevalence (%) by age, time and region in China, based on meta-analysisa
Variable
All Male Female
% 95% CI % 95% CI % 95% CI
Age (years)
40–49 1.2 1.0–1.3 1.2 0.9–1.6 0.9 0.6–1.1
50–59 2.9 2.6–3.2 4.2 3.3–5.1 2.7 2.1–3.3
60–69 5.9 5.2–6.5 7.8 6.5–9.2 5.9 4.8–7.0
≥70 8.7 8.0–9.5 12.0 10.0–13.9 9.4 7.9–11.0
Ftrend (age) 169.035 57.829 35.877
Ptrend value <0.001 <0.001 <0.001
Time/year
2000–2005 5.2 4.8–5.6 7.1 6.0–8.3 5.4 4.5–6.4
2006–2011 4.7 4.5–4.9 7.3 6.6–8.0 6.2 5.5–6.8
2012–2017 5.4 5.1–5.8 7.5 6.7–8.2 5.2 4.5–5.8
Ftrend (time) 0.123 0.004 0.113
Ptrend value 0.726 0.950 0.737
Region
North China 8.0 7.4–8.5 12.0 11.0–14.0 9.4 8.2–11.0
Northeast China 6.0 5.0–7.0 6.0 2.31–9.70 5.7 1.6–9.7
Northwest China 5.8 4.6–7.1 – – – –
Central China 5.0 4.7–5.4 4.0 1.8–6.1 3.3 1.2–5.4
East China 3.6 3.3–3.8 5.1 4.4–5.7 3.6 2.9–4.2
Southwest China 3.4 3.0–3.8 3.7 2.6–4.8 2.8 2.1–3.6
South China 3.1 2.5–3.6 2.4 1.8–3.0 1.8 1.4–2.3
a, the total rate was calculated by meta-analysis after age was standardized according to the sixth Chinese census data in 2010. –, no 
date.
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was significantly higher among residents living in the 
north than in the south of China (33.8% vs. 23.3%) (18). 
Differences in diet, lifestyle factors, and climate may also 
contribute to the regional discrepancy in stroke (19-21). 
One of the main dietary differences between the south 
and the north is the staple food. In the south, rice is the 
main staple, while wheat is the staple in the north. Rice 
consumption seems beneficial for maintaining healthy body 
weight and blood pressure. In one study conducted in east 
China, the proportion of rice consumed as the main staple 
food was inversely related to hypertension risk (22).
The prevalence increased with age, which is consistent 
with other studies (23-25). Stroke has traditionally been 
regarded as a disease for the elderly (25). However, various 
studies have revealed that stroke has become increasingly 
common in young and middle-aged adults (40–59 years) in 
recent years (10). We reported a prevalence of rate of 1.5% 
among individuals aged 40–49 in 2012–2017. This may 
be due to two underlying reasons. First, in recent years, 
hypertension, a risk factor for stroke (25,26), has become 
more prevalent among young and middle-aged adults 
(40–60 years) (27). Second, younger age groups have lower 
awareness and poorer management of stroke symptoms 
than older age groups (28).
The rapid increase of stroke rates among those aged 
40–59 years old might be largely attributed to early life 
exposure to the Chinese famine in 1959–1961. The major 
modifiable risk factors for stroke were hypertension, 
diabetes mellitus, tobacco smoking, and hyperlipidemia, as 
well as lifestyle factors such as obesity, poor diet/nutrition, 
and physical inactivity (29). Studies have shown that people 
born during the Chinese famine have an increased risk of 
diabetes, obesity, and hypertension (30,31). This may be due 
to the alterations in fetal nutrition and endocrine conditions 
Figure 2 Regional differences in prevalence (%) of stroke among adults aged ≥40 years old in China during 2000–2017: based on meta-
analysis of findings from 96 studies. 
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Southwest China 3.4 
East China 3.6
Central China 5.0 
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leading to developmental adaptations, which permanently 
changes the structure of the body, causing them to develop 
body fat during intrauterine development, thereby 
making individuals prone to cardiovascular, metabolic 
and endocrine diseases. Furthermore, early life famine 
exposure exacerbates the association between hypertension 
and cardiovascular disease (CVD), including stroke (32). 
Using data from the China Health and Retirement 
Longitudinal Study (CHARLS), it has been reported that 
there was an increasing gradient of CVD risk associated 
with hypertension across late childhood, mid-childhood, 
and early childhood and fetal exposure to the Chinese 
famine. The odds ratio (OR) of hypertension for CVD 
was 1.69, 2.35, 2.48, 3.35, and 1.40 in late childhood, mid-
childhood, early childhood, fetal stages, and non-exposed 
cohorts, respectively (24). To what degree the early life 
famine exposure contributed to stroke has not yet been well 
studied. However, the early life famine affects hypertension 
and may affect stroke to some extent. One study revealed 
that early-life exposure to a Dutch famine might have 
affected lifestyle in adulthood (33). However, the traditional 
lifestyle factor intervention may not be effective in the 
group in the Chinese setting. 
Stroke is more common among men than women 
(34,35). Our study revealed that the prevalence of stroke in 
men is 1.3 times higher than that in women. This gender 
difference is consistent with other studies conducted in 
China and elsewhere (36). Many factors may explain this 
observation. First, the prevalence of smoking and alcohol 
consumption is much higher in men than women in China 
Figure 3 Meta-analysis of stroke prevalence (%) by age group and gender in China (A) by age group (B) by gender (C) by age and gender.
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(62.4% vs. 3.4%, respectively, for smoking; and 33.0% 
vs. 2.0%, respectively, for alcohol consumption) (37,38). 
Smoking, an established and modifiable risk factor for 
stroke, accounts for 15–50% of all strokes, depending on 
age, gender, stroke subtype, and study population (39,40). 
Second, there is a gender difference in the perception and 
management of weight, which is another major risk factor 
for stroke. Women are more likely to better manage their 
weight than men (41), and men have a significantly higher 
prevalence of being overweight or obese (BMI ≥24.0) than 
their female counterparts (42). In general, it is well-known 
that obesity plays a key role in health outcomes (43). Third, 
the different sex hormones between the genders (e.g., 
estrogen) may also contribute to the gender difference in 
stroke prevalence (44,45).
This study has several main strengths: first, it summarizes 
the collective results from 96 studies. These studies 
covered large study samples, a wide range of geographic 
areas across China, and participants were more than 
18 years old. Second, we conducted a meta-analysis of the 
findings and estimated stroke rates using random effect 
models. Third, we included six studies that used nationally 
representative data; some other studies included samples as 
large as 726,451 participants. Furthermore, some studies 
included all regions in mainland China: the 31 provinces, 
autonomous regions, and municipalities.
This study has some limitations. First, we tested the time 
trends, but the timeline of the study was divided into three 
periods and did not show trends in stroke prevalence by 
years. Second, although we included six studies that used 
nationally representative data, those studies that provided 
only regional data covered the 23 provinces and autonomous 
regions in China. Additionally, the included studies were 
of different quality: 36 studies scored 1, 48 studies scored 
2, 1 study scored 3, 11 studies scored 4, and 0 study scored 
5. Third, we aggregated the data by seven regions across 
China, as only a limited number of studies provided data for 
each province. Collapsing the data by large regions may not 
present enough useful information for individual provinces 
in those regions. Finally, the 29 studies with gender-specific 
data provided a different prevalence estimate (higher) than 
the overall studies. Thus, our estimated overall stroke 
prevalence might be underestimated.
This study shows a large disease burden of stroke in 
China, with no sign of decline over the past two decades. 
With the population aging, China will face increasing 
challenges from chronic diseases, including stroke, and more 
related efforts are needed to build upon previous programs 
for stroke prevention, treatment, and management (46). 
The Chinese government has sponsored a series of large-
scale regional and nationwide studies to examine the risk 
factors for stroke and to implement some national programs 
to promote the prevention and treatment of stroke. China 
has developed relevant national guidelines accordingly 
(29,47-50). Since 2015, more than 2,500 hospitals have 
joined the national, hospital-based, stroke care quality 
assessment and improvement platform (51,52). However, 
it seems that the stroke prevention programs implemented 
in China over the past two decades may not be effective 
enough at controlling the prevalence of the disease. This 
is a significant deficit, since caring for stroke survivors has 
impacts ranging across all aspects of life, from personal to 
social. It can affect various aspects of the patients’ and their 
family members’ well-being, creating physical, mental, 
and financial stress. Further research and more effective 
interventions are necessary for addressing these issues. To 
monitor and optimize these programs, future regional and 
local stroke surveillance programs, especially for younger 
age groups, need to be enhanced.
In conclusion, this meta-analysis based on studies 
published during 2000–2017 showed that stroke prevalence 
varied significantly across regions, with the highest rate 
Table 2 Pooled stroke prevalence (%) by age and period in China, based on meta-analysis
Age (years)
2000–2005 2006–2011 2012–2017
% 95% CI % 95% CI % 95% CI
40–49 0.8 0.5–1.0 1.0 0.8–1.2 1.5 1.2–1.8
50–59 2.0 1.5–2.6 2.8 2.3–3.2 3.4 2.8–4.0
60–69 6.4 5.0–7.9 5.3 4.5–6.1 6.2 5.3–7.2
≥70 9.8 7.5–12.0 8.0 7.1–8.8 9.1 7.7–10.0
Note: Based on the findings from 96 studies.
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in north China and the lowest in southern China. People 
in the age group of 40–59 old, men, and people living in 
northern China have the highest prevalence of stroke. 
China needs to make more vigorous and effective efforts to 
address the ongoing public health issue of stroke.
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